The Mixed Lineage Leukemia (MLL) gene is commonly involved in translocations in infantile leukemia and is ampli®ed in some cases of adult myeloid leukemia. A homolog of MLL denoted MLL2, which represents the second human homolog of the Drosophila trithorax gene, was characterized by assembling ESTs, the KIAA0304 cDNA clone, RT ± PCR fragments and a new clone isolated from a cDNA phage library and compared to the available genomic sequence. The MLL2 gene maps to 19q13.1, a region of frequent rearrangement or ampli®cation in solid tumors. MLL2 consists of an 8.5 ± 9 kb transcript and spans 20 kb of genomic DNA. The predicted MLL2 protein possesses all of the major domains de®ned in MLL and the two genes have a similar genomic structure. We ®nd that MLL2 is ampli®ed in two of 14 pancreatic carcinoma cell lines and one of ®ve glioblastoma cell lines and is a likely critical gene in 19q13.1 ampli®cations. It is also a candidate for chromosomal rearrangements involving this chromosome locus. MLL2 is one additional mammalian trithorax-group gene with involvement in human cancer.
Introduction
The MLL gene was cloned from a region frequently involved in chromosomal translocations at 11q23 (Mitelman et al., 1997; Zieman-van der Poel et al., 1991) . There are at least 25 dierent chromosomal partners in these translocations and 18 genes fused to MLL have been cloned to date (Caldas and Aparicio, 1999; Osaka et al., 1999; Rowley, 1993; So et al., 1997) . MLL (also referred to as HRX, ALL-1 and Htrx1) is the human homolog of the Drosophila trithorax gene (Djabali et al., 1992; Domer et al., 1993; Gu et al., 1992; Tkachuk et al., 1992; Zieman-van der Poel et al., 1991) . Trithorax is itself a member of the trithorax group genes (trxG) whose principal identi®ed roles are as positive components of transcriptional memory during development (Breen et al., 1995; Breen and Harte, 1993) . Trithorax is a large (43000 residue) multidomain protein, widely expressed throughout embryonic development and adulthood. Trithorax is responsible for the maintenance, but not the initiation, of HOX gene expression (Breen et al., 1995; Breen and Harte, 1993) . Comparison between the Drosophila trithorax gene and its mouse, human and puer®sh homologs has revealed multiple conserved regions (Caldas et al., 1998; Ma et al., 1993; Tkachuk et al., 1992) . These include a cluster of PHD zinc ®ngers and the carboxy-terminal SET domain. Smaller regions with identity to domains present in other proteins are also recognized in the vertebrate homologs of trithorax. These include a DNA methyltransferase domain and three AT hooks in the amino-terminus (Caldas et al., 1998; Domer et al., 1993; Tkachuk et al., 1992) . The hypothesis that mammalian MLL has a regulatory function similar to trithorax has been supported by the targeted disruption of the murine Mll locus, in which animals display posterior homeotic transformations and abnormalities in HOX gene patterns of expression (Yu et al., 1995) .
Mammalian genomes have two homologs of the Drosophila Trx-group gene brahma and analysis of ESTs with homology to conserved domains in other Trx-group genes reveals that multiple homologs of trxlike and ASH1-like genes exist in the human genome (S Aparicio and C Caldas, data not shown). Using a combination of computerized data base searches, screening of cDNA phage libraries and RT ± PCR, we cloned a homolog of MLL denoted MLL2. We demonstrate that MLL2 is located on 19q13.1, a region often ampli®ed in pancreatic carcinomas and involved in translocations in glioblastomas and other tumors (Mitelman et al., 1997) . We have used FISH, Southern blot and slot blot analysis to determine whether MLL2 is involved in chromosomal translocations or ampli®ed in a series of pancreatic, breast, ovarian and brain cancer derived cell lines.
Results

Cloning of MLL2
A search of EST databases using MLL identi®ed several related non-MLL ESTs, including N99341, a 1.4 kb cDNA clone with homology to the SET domain of MLL and subsequently KIAA0304, a 6342 bp cDNA cloned from a size selected brain cDNA library with extensive homology to MLL (Nagase et al., 1997).
N99341 corresponds to the last 1.3 kb of KIAA0304, contains a poly(A) + tail and is likely an incompletely processed transcript, since it contains intronic sequences in its most 5' end. KIAA0304 has an open reading frame (frame 1) in the ®rst 627 bp of its 5' end and another open reading frame (frame 2) extending from nucleotide 742 to nucleotide 5929, followed by a 3' UTR of 323 bp. Both these reading frames have homology to MLL (data not shown). Hybridization of a probe corresponding to the 3' end of the predicted MLL2 gene to Northern blots containing human RNA, revealed a transcript of between 8.5 and 9 kb. The genomic sequence from the region encompassing MLL2 is contained within the previously available 45 kb cosmid clone F24109 (accession number: AD000671). This cosmid also contains at least two other genes: the putative transcription factor PWZ71/ PLZF2 located 5' to the MLL2 and a gene homologous to the 35 kd subunit of a splicing factor, U2AF, located 3' to MLL2.
The cDNA clone, KIAA0304, encompasses nucleotides 17 304 to 34 387 of cosmid F24109. We noted that KIAA0304 has similarity to MLL on both sides of the frameshifts present in this cDNA. Furthermore, there are regions of homology to MLL within the genomic sequence reported for the cosmid, F24109, which lie further 5' to the genomic sequences containing KIAA0304. We hypothesized that KIAA0304 might contain aberrantly spliced material, introducing the frameshifts. We therefore screened a human testis cDNA phage library from Clontech with a 1052 bp EcoRV/Sal1 fragment, representing the 5' end of KIAA0304. This resulted in the isolation of a clone (designated clone 36) containing a 3.2 kb fragment that was sequenced and extended from 16 633 ± 24 361 bp of F24109, with *800 bp of additional 5' sequences, joining and overlapping with 2.45 kb of KIAA0304. However, these 2450 nucleotides were identical to the 5' end of KIAA0304 and included the frameshifts. Multiple attempts at extending the gene sequence 5' from clone 36 by re-screening the testis cDNA library, screening the Clontech leukocyte derived cDNA library and 5' RACE using Marathon cDNA TM (Clontech) derived from either testis or leukocyte RNA, failed. We therefore turned to RT ± PCR to extend the cDNA contig. Primers were designed within putative 5' prime exons, identi®ed by homology to MLL or by exon prediction algorithms (GRAIL), within the sequence of the genomic clone F24109. RT ± PCR ampli®cation of MLL2 speci®c products was dicult, requiring multiple adjustments in the reaction conditions, probably due to the extremely GC rich sequence within the proposed 5' end. Several clones were obtained ( Figure  1 ) by introducing the PCR products into the TA vector (Invitrogen). The overall assembly of these sequences resulted in a contig of 8140 bp (accession no: AF186605), with an open reading frame (ORF) of 7815 nucleotides, encompassing the second open reading frame of KIAA0304, and predicted to encode a protein of 2605 amino acids.
Resolving the frameshifts PCR using a forward primer on exon 4 and a reverse primer on exon 10 of MLL2 produced a 1230 bp fragment from KIAA0304 and phage clone 36. In contrast, RT ± PCR reactions using cDNA derived from several human cell lines (LK1, LK2, HS578t, Capan-1 and Hela) ampli®ed a smaller sized band of 1 kb. This smaller product was cloned and sequenced and found to be identical to KIAA0304 in its 5' and 3' ends but missing 229 bp (nucleotides 614 ± 842 in KIAA0304 and 19 014 ± 19 242 in cosmid F24109), suggesting the larger fragment includes an intron (see Figure 2 ). This RT ± PCR generated sequence contained a contiguous open reading frame consistent with the similarities to MLL discussed above. Although it could not be visualized by ethidium bromide staining, the larger, 1.2 kb transcript corresponding to the KIAA0304 sequence was also present in these RT ± PCR reactions. This was established by Southern blotting the RT ± PCR products and probing with a PCR amplimer encompassing the frameshifts. As expected, this probe does not hybridize to the 1 kb product, but an intense signal is observed corresponding to a 1.2 kb band. To further quantitate the dierent transcripts, RT ± PCR reactions with the primers located within the frameshift sequence and the primers used above were performed in triplicate using cDNAs from three human cell lines (Capan-1, LK1 and EBV-immortalized lymphocytes). PCR ampli®cations were done for 5, 10, 15 and 20 cycles and products were run on an agarose gel and blotted. The PCR-Southern blot was then probed with a 600 bp RT ± PCR product, which included the frameshifts and anking open reading frames. After ten cycles, the fragments representing the open reading frame was present in greater quantity than the fragment including the frameshift (data not shown). Taken together, these results suggest that the transcript containing the frameshift represents a minority of the MLL2 mRNA and represents an unprocessed pre-mRNA. Figure 1 Physical map of MLL2 cDNA. In the upper half of the ®gure the MLL2 transcript is represented by the bar with exon boundaries marked by vertical lines.`A' indicates the alternative splice of exon 6, which would not aect the ORF.`B' denotes the site of the intron 7 sequence which disrupts the ORF in KIAA0304 and clone 36.`C' indicates a non spliced intron in clone N99341. In the lower half the MLL2 transcript is represented by the thick bold line. The vertical line through KIAA0304 and clone 36 at the 5' end of exon 8 represents the 229 bp intron 7 sequence which interrupts the ORF. AF104918 is a sequence from a partial MLL2 cDNA clone deposited in GeneBank. 1) to 4) represent the contig of cloned RT ± PCR fragments which extend the MLL2 sequence towards its 5' end Genomic structure of MLL2 An exon ± intron structure for MLL2 was determined by comparing the sequence from the 8140 bp cDNA contig to the genomic sequence of cosmid F24109 (see Figure 1 and Table 1 ). The gene contains 37 exons, although the transcription initiation site and precise 5' boundary of the ®rst exon remains to be determined. Careful analysis of the sequence in cosmid F24109, upstream of the experimentally determined 5' end of the transcript, reveals a continued open reading frame extending for an additional 877 nucleotides. Within this reading frame, there is a putative initiation ATG codon starting 328 nucleotides 5' of the 8140 bp MLL2 transcript. This would indicate a total transcript size of between 8460 and 9010 nucleotides, which corresponds to the size observed in the Northern blot (8.5 ± 9 kb, see below). If this ATG is con®rmed as the initiation codon, MLL2 would encode a protein of 2716 amino acids. The similarity between the genomic structure of MLL2 with MLL is remarkable (see Table 2 
Mapping of MLL2
The mapping of MLL2 to chromosome 19 was con®rmed by screening the UK HGMP monochromosomal somatic cell hybrid panel with a 220 bp PCR amplimer (forward primer on exon 4 and reverse primer on exon 5). Medium resolution mapping placing the gene on 19q13.1 was performed by screening both the Genebridge 4 and the Stanford G3 radiation hybrid panel using the same primers. The data vector for the Genebridge 4 panel was (022120210122000010101000-00101102000011101112 12000112 111012000101100112 -10120100210010001010-01) this was sent to the STS mirror of the Whitehead mapping server at http:// www.hgmp.mrc.ac.uk/cgi-bin/contig/rhmapper.pl. This places MLL2 6.29cR from D19S425 (1cR is approximately 270 kb). The data vector for the Stanford G3 Rh panel was 0000000000000000000000000000000000000-0000010000010000000100101000010010001000001. The data was sent to the Stanford Human Genetics Center radiation hybrid mapping server at http://wwwshge.stanford.edu/RH/rhserver. Two Point Maximum Likelihood Analysis results for submitted data placed MLL2 28.22 cR from SHGC-11909 (one cR is approximetly 26 kb). Mapping of MLL2 to 19q13 was con®rmed by FISH analysis of multiple cell lines.
Expression analysis
Clontech's multi-tissue Northern blots (MTN TM ) were probed with a 1.4 kb cDNA from the 3' end of the MLL2 transcript. A band corresponding to an 8.5 ± 9 kb transcript was seen in all tissues, but was most prominent in testis (data not shown). Attempts to quantitate the proportion of transcripts with the termination exon by hybridizing the blot to an`exon' probe containing the frameshift region failed, again suggesting that the amount of RNA containing the frameshifts is very low.
When RT ± PCR was performed using a forward primer on exon 5 of MLL2 and a reverse primer located between the two ORFs in KIAA0304 the PCR product included two ampli®cation products: one of the expected size 600 bp and a smaller fragment of 300 bp. The sequence of the larger fragment was identical to that in KIAA0304. The smaller band was missing a putative exon within KIAA0304 (MLL2 exon 6). This alternative spliced product would still produce a transcript with the stop codons.
Comparison of MLL2 with MLL, Mll, fMLL and trithorax
The overall alignment of the 2605 residue MLL2 protein predicted to be encoded by the 7815 bp assembled intact open reading frame and the 3969 amino acids MLL protein reveals they are almost identical in domains 2 (encompassing the PHD and ZNF zinc ®ngers, and ATA1 (ATA: ALL1, TRX, ALR)) and 4 (ATA2 (ATA: ALL1, TRX, ALR) and SET) (see Figure 3a and Table 2 ). Domain 1 corresponds to the aminoterminus of the protein inclusive of the methyltransferase (MT) homology domain and encompasses 1200 amino acids in MLL and only 900 amino acids in MLL2 (1000 if the putative ATG upstream of the 5' end of the ORF described here is real). Within this domain the blocks of homology (TRX1, TRX2 and MT) previously identi®ed in MLL, Mll and fMLL, the ortholog protein in Fugu rubripes (Caldas et al., 1998) , are highly conserved in MLL2. AT hooks 2 and 3 are also present in MLL2, and a small block of amino acids with homology to AT hook 1 was also identi®ed, although G replaces P in the proposed AT hook consensus`RGRP' (see Figure 3b ). Another two blocks of signi®cant sequence conservation between MLL, Mll and fMLL, located between TRX1 and TRX2, are also present in MLL2 (amino acids 492 ± 504 and 532 ± 559) (see Figure 3a ,b). Other blocks of homology previously identi®ed in MLL, Mll and fMLL within domain 1 (Caldas et al., 1998) are absent in MLL2.
Within domain 1 amino acids 241 ± 540 of MLL2 are 90% identical to WBP7, a mouse polypeptide previously identi®ed using functional screening of a cDNA library for WW domain interacting proteins (Bedford et al., 1997) . WBP7 is encoded by a cDNA which corresponds to the 5' end of a 8.5 ± 9 kb mouse transcript, the murine homolog of MLL2 (Mll2) that we have partially sequenced (S Aparicio and C Caldas unpublished results.) Domain 3 is largely encoded by exon 28 and this is signi®cantly smaller in MLL2 (431 versus 1416 amino acids in MLL). Within this large domain (*560 amino acids in MLL2, *1500 amino acids in MLL) there are only three small regions of homology between the two proteins: (i) the boundary of exons 27 and 28, just carboxy-terminal to ATA1 (see Figure  3 (a); (ii) a block of conserved amino acids we previously identi®ed in fMLL (GVDD in Figure 3) ; and (iii) a small block of amino acids encompassed within the minimal transactivation domain of MLL (MTAD in Figure 3 ; also conserved in Mll and fMLL).
Detection of MLL2 ampli®cations by FISH analysis
A¯uorescent in situ hybridization (FISH) based assay was used to identify cell lines with either translocations or ampli®cation involving the MLL2 gene. Initially FISH analysis included 14 pancreatic, one fibrosarcoma, and ®ve glioblastoma cell lines. Eight of the pancreatic carcinoma cell lines were selected because they are known to possess an ampli®cation site on chromosome 19q13.1 detected by comparative genome hybridization (CGH) (Curtis et al., 1998 and S-F Chin and C Caldas, unpublished results) . Subsequently, six breast and ®ve ovarian carcinoma cell lines were also studied by FISH, since ampli®cation of MLL2 was detected in one breast cell line by slot blot analysis, and moreover 19q13.1 ampli®cations have been previously reported in breast and ovarian carcinomas (Cheng et al., 1992; Tirkkonen et al., 1998) .
FISH results in pancreatic carcinoma cell lines The karyotypes and CGH analysis of AICPC-1, AICPC-2, BxPC-3, HPAC, PANC-1, and SU.86.86 have been published previously (Curtis et al., 1998 noted along this hsr (see Figure 4a and Table 3 ). SU.86.86 cells have two normal chromosome 19s and one chromosome containing an hsr. FISH analysis revealed multiple MLL2 gene speci®c signals in the hsr, demonstrating its ampli®cation (see Figure 4b and Table 3 ). In contrast, MLL2 does not appear to be involved in the amplicon of the hsr found in PANC-1. In several of the other cell lines, MLL2 copy number increase due to chromosome 19 copy number changes and/or complex chromosome rearrangements were noted. Although some of these cell lines had chromosomal translocations involving 19q, in none of these was the MLL2 probe located at the breakpoint. Table 3 ). T98G contained multiple copies of two chromosome 19 markers with the four cosmid probe signal split at the fusion breakpoint. Further analysis using the cosmid containing MLL2, F24109, and the cosmid immediately telomeric to it, F25965, demonstrated that the chromosome 19 breakpoint was within F25965 but not F24109.
FISH results in breast carcinoma cell lines Six breast carcinoma cell lines were analysed by FISH. MDA-MB-157 (included after ampli®cation of MLL2 was detected by slot blot; see below), had four MLL2 copies. Two other cell lines (MATU and SKBR3) revealed MLL2 copy number increases secondary to complex chromosomal rearrangements.
FISH results in ovarian carcinoma and ®brosarcoma derived cell lines MLL2 copy number increases secondary to complex chromosome rearrangements were seen in two ovarian cell lines (OC315, SHIN3) and the ®brosarcoma cell line. Information for the MLL gene is based on data previously published (Gu et al., 1994; Marschalek et al., 1995; Rasio et al., 1996; Wiedemann et al., 1999) The amino acid similarity and identity ®gures were generated by an exon by exon comparison using the GCG program, GAP (Genetics Computer Group, Version 9, Madison, Wisconsin USA). COriginal exon number ins of MLL (Domer et al., 1993; Gu et al., 1992; Rasio et al., 1996) ; # Corrected exon numbering of MLL (Nilson et al., 1996) MLL2 maps to 19q13.1 and is amplified in tumor cell lines DG Huntsman et al
Con®rmation and detection of MLL2 ampli®cations by slot blot and Southern blot analysis
Slot blot analysis of 33 cell lines revealed that the pancreatic carcinoma cell line AICPC-1, the glioblastoma cell line H4, and the breast cancer cell line MDA-MB 157, had ampli®cation of MLL2. DNA from ten pancreatic carcinoma cell lines was analysed by Southern blot and the resulting bands scanned by densitometry. Capan-1 (normal by FISH and slot blot analysis) was used to normalize the intensity of the bands. Su86.86 and Panc-1 had ampli®ed MLL2 signals. Panc-1 and MDA-MB 157 had four copies of MLL2 by FISH, one in each chromosome 19 or chromosome 19 marker, and therefore no true gene ampli®cation.
No abnormally sized restriction fragments were identi®ed by Southern blot analysis of ten pancreatic carcinoma cell lines, 17 primary glioblastoma multiforme, ten glioblastoma multiforme-derived cell lines, 13 ovarian carcinoma cell lines and ten breast carcinoma cell lines. Although this result cannot rule out the presence of all possible translocations involving MLL2 in these specimens, the cDNA probe used would have detected translocations in the region of MLL2 homologous to the breakpoint cluster region of MLL.
Discussion
We describe the isolation and characterization of MLL2, a second human homolog of Drosophila trithorax. The comparison of MLL2 with MLL reveals some remarkable features: MLL2 is only 66% of the size of MLL (68% if including the 109 amino acids encoded by the ORF upstream of the 5' end of the cDNA contig here described). Despite this dierence in size, MLL2 includes all the conserved domains identi®ed in MLL as compared with Trx and most of the conserved domains identi®ed in the vertebrate homologs MLL, Mll and fMLL. This degree of homology would suggest that both proteins have at least some overlapping functions. The WBP7 domain, which overlaps AT hook 3, TRX1 and the two conserved blocks also present in fMLL (but not identi®able as such in MLL) appears to mediate, at least in vitro, interactions with WW and SH3 domains (Bedford et al., 1997) , suggesting that MLL2 has evolved divergent functions. Interestingly, the comparison of MLL2 with other vertebrate homologs of Trx appears to con®rm a particular motif underlying the MTAD de®ned by alanine mutagenesis scan and further supports the existence of a proposed novel Q(L/ V)DG(V/A)DD motif, which we previously described, c the rate of ampli®cation is de®ned as the number of gene copies divided by the modal number of chromosomes 623 present in Trx, MLL and fMLL (Caldas et al., 1998; Prasad et al., 1995) .
The extensive and signi®cant similarity between MLL2 and MLL, including a conserved exon ± intron structure, and the location of MLL2 to a site of frequent rearrangements and ampli®cations in human cancers, immediately suggested the potential involvement of this gene in tumorigenesis. MLL2 was mapped to 19q13.1 by radiation hybrid panels, a site to where the cosmid containing this gene was also physically mapped (www-bio.llnl-gov/genome/genome/ html). Translocations and ampli®cations of 19q13.1 have been commonly identi®ed in human cancer (Mitelman et al., 1997) . This resembles the 11q23 region containing MLL, a frequent site of rearrangement in human cancer (Mitelman et al., 1997) . MLL is involved in human leukemias and solid malignancies by several dierent mechanisms: translocations with fusion to several partner genes, partial genomic duplication, internal deletion and ampli®cation (Allen et al., 1998; Ariyama et al., 1998; Baa et al., 1995; Felix et al., 1998; Lochner et al., 1996; Michaux et al., 1998; Schichman et al., 1994a,b; Tanaka et al., 1997) . We therefore reasoned that MLL2 might be involved in both translocations and ampli®cations at 19q13.1. We failed to detect any translocations targeting MLL2 and independently con®rmed previous observations that exclude MLL2 as the target of 19q13.1 translocations in the glioblastoma cell line T98G (Chernova et al., 1998) . Similarly in several other cell lines, MLL2 was located near but was not disrupted by 19q13.1 translocations. DNA sequences from 19q13.1 have been shown to be ampli®ed in pancreatic carcinoma cell lines and primary pancreatic cancers and the corresponding genes overexpressed in pancreatic carcinomas (Cheng et al., 1996; Curtis et al., 1998; Ferbus et al., 1999; Hoglund et al., 1998) . Of 12 pancreatic carcinoma cell lines analysed by both conventional cytogenetics and CGH, six showed ampli®cation of 19q13.1 (Curtis et al., 1998) . Three of these cell lines had high level ampli®cation of a series of overlapping NotI restriction fragments from 19q13.1 (Curtis et al., 1998) . SU86.86 and AICPC-1 had ampli®cation of both OZF and AKT2, whilst PANC-1 only exhibited ampli®cation of AKT2 (Curtis et al., 1998) . SU86.86 and AICP-1 were the only representatives of the 14 pancreatic carcinoma cell lines studied here, with ampli®cation of MLL2 as detected by both FISH and blotting methods. Therefore, in these two cell lines, the three genes (MLL2, AKT2 and OZF) appear to be co-ampli®ed. In contrast, PANC1 appears to have only an ampli®cation of AKT2. Ampli®cation of MLL2 was also detected in the glioblastoma multiforme cell line, H4. In this cell line the ampli®ed signal is on a marker chromosome 6 with 19q13-tel material. The ampli®ed signal (at least four copies on each side of the marker isochromosome) is located at 19q adjacent to the breakpoint but Southern blot analysis of this cell line failed to show an MLL2 rearrangement. Taken together, these results suggest that it is unlikely that MLL2 is directly involved in these translocations.
Genomic ampli®cations usually involve multiple genes and it can be dicult to determine which one of a group of genes within a region of genomic ampli®cation is the critical component of that rearrangement. Genomic ampli®cation of MLL has been reported as a recurrent change in adult onset myeloid leukemias (Michaux et al., 1998 ) and therefore we suggest that its homolog, MLL2, is a critical component of the 19q13.1 ampli®cations described here. MLL along with other members of the Trithorax/polycomb group of proteins control the expression of HOX and other developmental genes through chromatin modi®cation (Gould, 1997) . It is important to note that evidence from genetic experiments which alter the dosage of trx/MLL show that the regulation of dosage is important (Gould et al., 1990; Yu et al., 1995) . Furthermore, SET domain functions have recently been linked to growth and cell cycle control through interactions with dual speci®city phosphatases (Cui et al., 1998) . Although MLL2 does not appear to be directly involved in any translocation in the cell lines examined, it is ampli®ed in three cell lines and MLL2 copy number increases due to complex chromosomal rearrangements were commonly seen suggesting that misregulation of MLL2 could be an important mechanism of tumorigenesis. The data presented here will facilitate the eventual clari®cation of MLL2 involvement in 19q13.1 abnormalities in human cancers.
Materials and methods
Tumor cell lines
Cell lines were purchased from ATCC or obtained by generous contribution from other investigators and grown under standard protocols.
DNA and cDNA isolation DNA was extracted from cell pellets by proteinase-K digestion followed by treatment with RNA-ase A, phenol chloroform extraction and precipitation with ethanol. RNA was extracted with Trizol TM (Gibco BRL) using the recommended protocol. cDNA was made by random priming of RNA with hexamers using Superscript II (Gibco BRL).
PCR and RT ± PCR
Ampli®cation was performed using dierent buers (1 ± 2.25 mM MgCl 2 , 15 mM Tris-HCl (pH 8.8), 60 mM KCl; 2 ± 20 mM (NH 4 ) 2 SO 4 , 75 mM Tris-HCl (pH 9.0), 0.01% (w/ w) Tween, 1 ± 3 mM MgCl 2 ; 3 ± 16.6 mM (NH 4 ) 2 SO 4 , 67 mM Tris-HCl (pH 8.8), 6.7 mM MgCl 2 , 10 mM b-Mercaptoethanol, 100 mg/ml bovine serum albumin), with (2.5 ± 10%) or without DMSO, on an Hybaid TouchDown thermal cycler. Sequence of primers and speci®c PCR conditions are available upon request.
Phage cDNA library
Both the human testes and human leukocyte 5'-STRETCH PLUS TM phage cDNA libraries (Clontech) were screened using a 1 kb KIAA0304 5' end cDNA probe. The libraries were screened using the protocols recommended by Clontech and DNA was extracted from plaque pure clones by a cesium chloride protocol.
Sequencing
DNA sequencing of all clones was performed on both strands using TaqFS and an ABI377 or an ABI373 sequencer (Applied Biosystems, Foster, CA, USA). The sequences of published clones were obtained from the NCBI.
Expression analysis
Multi-tissue Northern blots from Clontech were probed according to recommended protocol using a 1.4 kb cDNA probe of MLL2 obtained by NotI/HindIII digestion of IMAGE clone 53610 (EST N99341).
Slot blot analysis
Slot blot analysis was performed using DNA from eight pancreatic carcinoma, two glioblastoma, 13 breast carcinoma, and nine ovarian carcinoma cell lines. DNA from two lymphoblastoid cell lines was used as control. The DNA was arrayed using a Schleicher and Schuell SRC072/ 0 micro-sample ®ltration manifold. Five micrograms of DNA was denatured in 0.4 M NaOH and arrayed onto Hybond-N +TM nylon membrane (Amersham Pharmacia) with each cell line represented in duplicate. The membranes were probed with a 1052 bp EcoRV/SalI fragment from the 5' end of KIAA0304. The PCR amplimers D19S298 from the centromeric region of 19p, T69305 from the telomeric region of 19q and a 400 bp GAPDH fragment were used as controls. Probes were labeled with 32 P-dCTP (Redivue TM , Amersham Pharmacia) using the Rediprime TM II kit (Amersham Pharmacia Biotech). Hybridization was performed in 6% w/v NaCl, 5% w/v Dextran sulfhate, 1% SDS at 658C. Membranes were washed with 0.1% SSC/ 0.1% SDS at room temperature and then at 55 ± 658C. Autoradiographs were scanned by densitometry (BioRad model GS-700 Imaging). The normalized MLL2 signal was calculated by comparing the intensity of the bands for the MLL2 and control probes in the tested cell line DNA with the intensity of the corresponding bands in the control DNA.
Southern blot analysis DNA (10 mg) from ten pancreatic carcinoma cell lines was digested with XbaI overnight, run on a 0.8% agarose gel and transferred to Hybond-N +TM nylon membrane (Amersham Pharmacia). The membrane was probed with the 1 kb KIA0304 probe and a c-MYC cDNA probe. Labeling, hybridization and analysis of the autoradiographs was performed with the protocols outlined above. Other DNA samples analysed by Southern blot included: (i) XbaI digests from 17 glioblastoma multiforme primary tumor specimens and from ten glioblastoma multiforme cell lines; (ii) BamHI, HindIII and PstI digests from 13 ovarian carcinoma cell lines; and (iii) PstI digests of ten breast carcinoma cell lines.
FISH
FISH analysis was used to detect ampli®cation or rearrangement of MLL2 in 25 carcinoma cell lines (14 pancreatic, six breast and ®ve ovarian) and in ®ve glioblastoma cell lines. Two gene speci®c cosmid probes were used (obtained from Lawrence Livermore National Laboratory in the USA): a 125 kb contig (cosmids R28052, F24109, F16351 and F25965), or a single cosmid (F24109, which contains the MLL2 gene). FISH was performed using standard techniques (Muleris et al., 1994) . Single copy probes were labeled with digoxigenin by nick translation while chromosome 19 paint was labeled with biotin by DOP-PCR. Labeled probes were co-precipitated with ten to 200-fold excess of human competitor DNA.
Digoxigenin labeled probes were visualized using ligandspeci®c antibodies conjugated to¯uorescein isothiocyanate (FITC) and biotin labeled chromosome paint was visualized using avidin-Texas red. Slides were counterstained in Vectorshield (Vector Laboratories, CA, USA) containing DAPI and visualized using a¯uorescence microscope equipped with a triple band pass ®lter. Images were captured using SmartCapture Viewpoint Software (Vysis, II, USA).
Note added in proof
Coinciding with submission of this article, one additional report (FitzGerald and Diaz, 1999) described the identification of a partial MLL2 cDNA, which corresponds to exons 4 ± 37 of the sequence described here. In addition, one 8469 bp cDNA sequence, designated trithorax homologue 2, has been deposited in GenBank (AJ007041) and is identical to the cDNA described here (one single bp dierence) and extends it further 5' by 329 bp.
